LH vs NOV · P/E 23, rev $13.95B vs P/E 86, rev $8.74B
Laboratory Corporation of America Holdings (LH) versus NOV Inc. (NOV) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
NOV Inc. (NOV) is a oil & gas equipment & services company listed on US.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Latest reported NOV revenue for 2025-12-31 was $8.74B. Net income was $145.0M. Revenue was down 1.4% from 2024-12-31 to 2025-12-31. NOV currently screens at market cap $7.70B and trailing P/E 85.8.
LH currently screens at market cap $21.07B and trailing P/E 22.8. NOV currently screens at market cap $7.70B and trailing P/E 85.8.
Not investment advice. Open the LH and NOV stock pages for the full models.
Not investment advice.